CA2374117A1 - Formulations comprenant des agents regulateurs des lipides - Google Patents
Formulations comprenant des agents regulateurs des lipides Download PDFInfo
- Publication number
- CA2374117A1 CA2374117A1 CA002374117A CA2374117A CA2374117A1 CA 2374117 A1 CA2374117 A1 CA 2374117A1 CA 002374117 A CA002374117 A CA 002374117A CA 2374117 A CA2374117 A CA 2374117A CA 2374117 A1 CA2374117 A1 CA 2374117A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- lipid
- excipient
- fenofibrate
- regulating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une formulation solide faite d'un mélange d'agent régulateur des lipides et d'un excipient, en l'occurrence un mélange eutectique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32318399A | 1999-05-28 | 1999-05-28 | |
US09/323,183 | 1999-05-28 | ||
PCT/US2000/014109 WO2000072829A1 (fr) | 1999-05-28 | 2000-05-23 | Formulations comprenant des agents regulateurs des lipides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2374117A1 true CA2374117A1 (fr) | 2000-12-07 |
Family
ID=23258077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002374117A Abandoned CA2374117A1 (fr) | 1999-05-28 | 2000-05-23 | Formulations comprenant des agents regulateurs des lipides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1183017A1 (fr) |
JP (1) | JP2003500439A (fr) |
CA (1) | CA2374117A1 (fr) |
MX (1) | MXPA01012225A (fr) |
WO (1) | WO2000072829A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276249B2 (en) | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
US8273794B2 (en) * | 2004-05-14 | 2012-09-25 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
GB2441499B (en) * | 2006-09-08 | 2011-09-14 | Jasin El Sammadoni | Slimming Spray |
EP2200588B1 (fr) | 2007-09-25 | 2019-03-20 | Solubest Ltd. | Compositions comprenant des composés actifs lipophiles et procédé pour leur préparation |
KR101569227B1 (ko) | 2008-03-11 | 2015-11-13 | 아스카 세이야쿠 가부시키가이샤 | 고체 분산체와 그 의약 조성물, 그리고 그들의 제조 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2157201C3 (de) * | 1970-11-13 | 1974-12-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verbesserte feste orale Applikationsform von Raubasin |
IT1180507B (it) * | 1984-06-29 | 1987-09-23 | Roberto Valducci | Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento |
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
AU671811B2 (en) * | 1991-12-18 | 1996-09-12 | Warner-Lambert Company | A process for the preparation of a solid dispersion |
-
2000
- 2000-05-23 CA CA002374117A patent/CA2374117A1/fr not_active Abandoned
- 2000-05-23 EP EP00937680A patent/EP1183017A1/fr not_active Withdrawn
- 2000-05-23 WO PCT/US2000/014109 patent/WO2000072829A1/fr not_active Application Discontinuation
- 2000-05-23 MX MXPA01012225A patent/MXPA01012225A/es not_active Application Discontinuation
- 2000-05-23 JP JP2000620941A patent/JP2003500439A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MXPA01012225A (es) | 2002-08-12 |
JP2003500439A (ja) | 2003-01-07 |
WO2000072829A1 (fr) | 2000-12-07 |
EP1183017A1 (fr) | 2002-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6465011B2 (en) | Formulations comprising lipid-regulating agents | |
US6372251B2 (en) | Formulations comprising lipid-regulating agents | |
US4404183A (en) | Sustained release pharmaceutical composition of solid medical material | |
EP0142561B1 (fr) | Preparation a base de nifedipine a action prolongee | |
US6368622B2 (en) | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption | |
US6383517B1 (en) | Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption | |
EP1162954A1 (fr) | Preparations contenant des agents regulateurs de lipides | |
KR20100038188A (ko) | 수분산성 건성 약학적 조성물의 신규 제조 방법 및 그에 의해 수득한 약학적 조성물 | |
MX2007012124A (es) | Formulaciones mejoradas de fenofibrato. | |
EP1140036A2 (fr) | Formulations comprenant des liporegulateurs | |
US6838091B2 (en) | Formulations comprising lipid-regulating agents | |
JPH0157090B2 (fr) | ||
US6814977B1 (en) | Formulations comprising lipid-regulating agents | |
US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
CA2374117A1 (fr) | Formulations comprenant des agents regulateurs des lipides | |
JP2004536826A (ja) | プラバスタチンを含む安定な薬剤組成物 | |
US20020040046A1 (en) | Novel formulations comprising lipid-regulating agents | |
US7014864B1 (en) | Formulations comprising lipid-regulating agents | |
CA2531097C (fr) | Procede de preparation de produits formules de medicaments de regulation du metabolisme lipidique | |
US20060177512A1 (en) | Process for preparing formulations of lipid-regulating drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |